Thyroid function and lipid profile in bipolar I patients

Asian Journal of Psychiatry

Volumn 4, Issue 2, 2011, Pages 139-143

  Ezzaher, Asma ^a   Haj Mouhamed, Dhouha ^a   Mechri, Anwar ^a   Neffati, Fadoua ^a   Douki, Wahiba ^a   Gaha, Lotfi ^a   Najjar, Mohamed Fadhel ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Bipolar I disorder; Hypothyroidism; Lipid profile; Obesity

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LITHIUM; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL; VALPROIC ACID;

ADULT; BIPOLAR I DISORDER; CHEMOLUMINESCENCE; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; ELECTROCHEMILUMINESCENCE; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOTURBIDIMETRY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; REVIEW; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TURBIDIMETRY;

EID: 79958769511     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2011.02.002     Document Type: Review

References (22)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2004, American Psychiatric Association, Washington, DC. 4th edition.
2. Bartalena L., Pellegrini L., Meschi M., Antonangeli L., Bogazzi F., Dell'osso L. Evaluation of thyroid function in patients with rapid-cycling and non-rapid-cycling bipolar disorder. Psychiatry Res. 1990, 34:13-17.
3. Bauer M., Heinz A., Whybrow P.C. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry 2002, 7:140-156.
4. Bauer M., London E.D., Silverman D.H., Rasgon N., Kirchheiner J., Whybrow P.C. Thyroid, brain and mood modulation in affective disorder: insights from molecular research and functional brain imaging. Pharmacopsychiatry 2003, 36:S215-S221.
5. Baumgartner A., Pinna G., Hiedra L., Gaio U., Hessenius C., Campos-Barros A., et al. Effects of lithium and carbamazepine on thyroid hormone metabolism in rat brain. Neuropsychopharmacology 1997, 16:25-41.
6. Cappola A.R., Ladenson P.W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 2003, 88:2438-2444.
7. Carlé A., Laurberg P., Pedersen I.B., Knudsen N., Perrild H., Ovesen L. Epidemiology of subtypes of hypothyroidism in Denmark. Eur. J. Endocrinol. 2006, 154:21-28.
8. Chung K.H., Tsai S.Y., Lee H.C. Mood symptoms and serum lipids in acute phase of bipolar disorder in Taiwan. Psychiatry Clin. Neurosci. 2007, 61:428-433.
9. Eker S.S., Akkaya C., Sarandol A., Cangur S., Sarandol E., Kirli S. Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:955-961.
10. Ezzaher A., Haj Mouhamed D., Mechri A., Araoud M., Neffati F., Douki W., et al. Lower paraoxonase 1 activity in Tunisian bipolar I patients. Ann. Gen. Psychiatry 2010, 9:36.
11. Fagiolini A., Frank E., Scott J.A., Turkin S., Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005, 7:424-430.
12. Garcia-Portilla M.P., Saiz P.A., Bascaran M.T., Martinez S., Benabarre A., Sierra P., et al. Cardiovascular risk in patients with bipolar disorder. J. Affect. Disord. 2009, 115:1-7.
13. Gau C.S., Chang C.J., Tsai F.J., Chao P.F., Gau S.S. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study. Bipolar Disord. 2010, 12:253-263.
14. Lombardi G., Panza N., Biondi B., Di Lorenzo L., Lupoli G., Muscettola G., et al. Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study. J. Endocrinol. Invest. 1993, 16:259-263.
15. Marmol F. Lithium: bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1761-1771.
16. Mikati M.A., Tarabay H., Khalil A., Rahi A.C., Banna E.L., Najjar D.S. Risk factors for development of subclinical hypothyroidism during valproic acid therapy. J. Pediatr. 2007, 151:178-181.
17. Pearce E.N., Wilson P.W.F., Yang Q., Vasan R.S., Braverman L.E. Thyroid function and lipid subparticle sizes in patients with short-term hypothyroidism and a population-based cohort. J. Clin. Endocrinol. Metab. 2007, 93:888-894.
18. Reinehr T. Obesity and thyroid function. Mol. Cell. Endocrinol. 2010, 316:165-171.
19. Sicras A., Rejas J., Navarro R., Serrat J., Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord. 2008, 10:607-616.
20. Soreca I., Fagiolini A., Frank E., Houck P.R., Thompson W.K., Kupfer D.J. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J. Psychiatr. Res. 2008, 42:956-961.
21. Valle J., Ayuso-Gutierrez J.L., Abril A., Ayuso-Mateos J.L. Evaluation of thyroid function in lithium-naive bipolar patients. Eur. Psychiatry 1999, 14:341-345.
22. World Health Organization Obesity: Preventing and Managing the Global Epidemic (publication WHO/NUT/NCD/98.1) 1997, Geneva, Switzerland.